Usted buscó: pneumococcal (Inglés - Maltés)

pneumococcal infections
l-infezzjonijiet pnewmokoċċi

invasive pneumococcal disease
mard pnewmokokkali invażiv

pneumococcal conjugate vaccine (pcv)
tilqima konjugata tal-pneumococcus (pcv).

prevenar is a pneumococcal vaccine.
prevenar hu tilqima pnewmokokkali.

pneumococcal polysaccharide serotype 11 2.2 µg
polysaccharide pnewmokokkali serotip 11 2.2 µg

pneumococcal polysaccharide serotype 11,2 1 microgram
polysaccharide pnewmokokkali serotip 11,2 mikrogramma waħda

pneumococcal polysaccharide conjugate vaccine (adsorbed)
vaċċin konjugat (adsorbit) ta’ polysaccharide pnewmokokkali

187 multivalent pneumococcal polysaccharide vaccine at week 4.
fi studju kliniku randomizzat, double blind, ikkontrollat bi plaċebo f’ pazjenti adulti b’ artrite psorjatika, 184 pazjenti ngħataw ukoll multivalent pneumococcal polysaccharide vaccine fir- 4 ġimgħa.

prevenar 13 is a pneumococcal vaccine given to:
prevenar 13 hu vaċċin pnewmokokkali mogħti lil:

pneumococcal saccharide conjugated vaccine, adsorbed intramuscular use.
tilqima konjugata saccharide pnewmokokkali, adsorbita użu għal ġol-muskoli.

pharmacotherapeutic group: pneumococcal vaccines, atc code: j07al52
kategorija farmakoterapewtika: tilqim pnewmokokkali, kodiċi atc: j07al52

21, 45) reduction in the incidence of all pneumococcal aom.
21, 45) fl- inċidenza tal- aoms pnewmokokkali kollha.

pneumococcal polysaccharide conjugate vaccine (13 valent, adsorbed)
tilqima ta’ konjugat (13 valent, adsorbit) ta’ polysaccharide pnewmokokkali

adults previously vaccinated with 23-valent pneumococcal polysaccharide vaccine
adulti li preċedentement tlaqqmu bil-vaċċin polisakkaride pnewmokokkali ta’ 23-valenti

adults not previously vaccinated with 23-valent pneumococcal polysaccharide vaccine
adulti li ma kinux tlaqqmu qabel bil-vaċċin polisakkaride pnewmokokkali ta’ 23-valenti

pharmacotherapeutic group: vaccines, pneumococcal vaccines; atc code: j07al02
kategorija farmakoterapewtika: tilqim, tilqim pnewmokokkali; kodiċi atc: j07al02

42%), reduced rates to pneumococcal polysaccharide vaccine (43% vs.
42%), u rati

prevenar suspension for injection pneumococcal saccharide conjugated vaccine, adsorbed intramuscular use.
prevenar suspensjoni għall- injezzjoni tilqima konjugata saccharide pnewmokokkali, adsorbita użu għal ġol- muskoli.

a pneumococcal vaccine administered 6 weeks after discontinuation of raptiva yielded normal results.
tilqima tal-pnemuococcal li ngħata 6 ġimgħat wara li twqqaf ir-raptiva tagħ rizultati normali.

adults 18-49 years not previously vaccinated with 23-valent pneumococcal polysaccharide vaccine
adulti li kellhom 18-49 sena li fil- passat ma ġewx imlaqqma b’tilqima tal-polysaccharide pnewmokokkali ta’ 23 valent